IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.
Polymorphisms of human Fc receptors (FcRs) have been described that are associated with the development or progression of autoimmune diseases. The FcR polymorphisms affect the affinity with which FcRs interact with immunoglobulin molecules. Intravenous immunoglobulin is administered as therapy for many autoimmune diseases and might exert its effects by interacting with FcRs. Thus, FcR polymorphisms might influence the efficacy of intravenous immunoglobulin therapy for patients with certain autoimmune diseases. In this article we review FcR polymorphisms in relation to autoimmune diseases for which intravenous immunoglobulin is used therapeutically.
Binstadt
Bryce A
BA
Division of Immunology, Children's Hospital Boston, MA 02115, USA.
Geha
Raif S
RS
Bonilla
Francisco A
FA
D001327:Autoimmune Diseases / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D014890:Granulomatosis with Polyangiitis / Q000235:genetics / Q000276:immunology / Q000628:therapy; D020275:Guillain-Barre Syndrome / Q000235:genetics / Q000276:immunology / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology / Q000628:therapy; D011110:Polymorphism, Genetic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000235:genetics / Q000276:immunology / Q000628:therapy; D017452:Receptors, IgG / Q000235:genetics*
D016756:Immunoglobulins, Intravenous; D017452:Receptors, IgG